Financial Ratios

CAPLIN POINT LABORATORIES LTD.

NSE : CAPLIPOINTBSE : 524742ISIN CODE : INE475E01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE2205.000.4 (+0.02 %)
PREV CLOSE ( ) 2204.60
OPEN PRICE ( ) 2208.75
BID PRICE (QTY) 2204.85 (6)
OFFER PRICE (QTY) 2208.95 (43)
VOLUME 2600
TODAY'S LOW / HIGH ( )2168.35 2227.00
52 WK LOW / HIGH ( )1221 2636
NSE2210.103.85 (+0.17 %)
PREV CLOSE( ) 2206.25
OPEN PRICE ( ) 2210.00
BID PRICE (QTY) 2210.10 (61)
OFFER PRICE (QTY) 2211.90 (1)
VOLUME 84264
TODAY'S LOW / HIGH( ) 2166.00 2227.80
52 WK LOW / HIGH ( )1225 2641
Select year
ParticularsMar2024Mar2023Mar2022Mar2021Mar2020
Operational & Financial Ratios
   Earnings Per Share (Rs)37.3530.8624.7920.6526.13
   CEPS(Rs)40.9234.2428.1823.6228.73
   DPS(Rs)5.004.504.003.002.50
   Book NAV/Share(Rs)181.16148.16120.7498.3378.06
   Tax Rate(%)22.4320.0924.9525.5821.92
Margin Ratios
   Core EBITDA Margin(%)45.9341.5041.5643.4139.22
   EBIT Margin(%)58.5355.4847.4243.5347.99
   Pre Tax Margin(%)58.5155.4647.4043.4947.96
   PAT Margin (%)45.3944.3235.5832.3737.44
   Cash Profit Margin (%)49.7249.1740.4637.0241.17
Performance Ratios
   ROA(%)20.0819.8719.6220.1332.12
   ROE(%)22.6922.9722.6523.4238.92
   ROCE(%)28.9228.3329.6430.9249.05
   Asset Turnover(x)0.440.450.550.620.86
   Sales/Fixed Asset(x)2.071.911.971.952.59
   Working Capital/Sales(x)1.071.031.041.111.67
Efficiency Ratios
   Fixed Capital/Sales(x)0.480.520.510.510.39
   Receivable days63.3349.0152.60120.02119.07
   Inventory Days40.2332.5723.3917.8615.87
   Payable days132.73124.99120.50113.8384.99
Valuation Parameters
   PER(x)35.2619.3327.4319.5710.81
   PCE(x)32.1917.4324.1217.119.83
   Price/Book(x)7.274.035.634.113.62
   Yield(%)0.380.750.590.740.89
   EV/Net Sales(x)15.668.059.165.623.94
   EV/Core EBITDA(x)24.9113.3517.5211.667.61
   EV/EBIT(x)26.7614.5219.3212.918.20
   EV/CE(x)7.043.744.593.153.01
   M Cap / Sales16.018.579.766.334.05
Growth Ratio
   Net Sales Growth(%)18.250.109.40-8.55-1.69
   Core EBITDA Growth(%)23.2015.4818.76-14.8121.86
   EBIT Growth(%)24.7517.1219.18-17.0524.69
   PAT Growth(%)21.1124.6920.25-20.9533.39
   EPS Growth(%)21.0324.5320.01-20.9633.37
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)5.894.516.136.635.93
   Quick Ratio(x)5.174.165.696.315.58
   Interest Cover(x)3658.402443.922782.221235.941369.24
   Total Debt/Mcap(x)0.000.000.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.